Human HPV-IgG ELISA Kit |
MBS3802098-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human IgG antibody Laboratories manufactures the accurun hpv dichiarazione conformità reagents distributed by Genprice. The Accurun Hpv Dichiarazione Conformità reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SeraCare Inc.. Other Accurun products are available in stock. Specificity: Accurun Category: Hpv Group: Dichiarazione Conformità
Human Papillomavirus IgG (HPV IgG) ELISA Kit |
Abbexa |
100 µg |
Ask for price |
Human Papillomavirus IgG (HPV IgG) ELISA Kit |
Abbexa |
10 µg |
EUR 493.75 |
Human Papillomavirus IgG (HPV IgG) ELISA Kit |
Abbexa |
50 µg |
Ask for price |
Human papillomavirus IgG (HPV-IgG) ELISA Kit |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human papillomavirus IgG (HPV-IgG) ELISA Kit |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Dichiarazione Conformità information
Chimeric Rabbit Anti-RSV pre- and postfusion conformation of HRSV F protein monoclonal antibody, clone STC26 |
CABT-L2690 |
Creative Diagnostics |
200 µg |
EUR 987 |
|
Description: Rabbit |
Chimeric Rabbit Anti-RSV pre- and postfusion conformation of HRSV F protein monoclonal antibody, clone STC27 |
CABT-L2692 |
Creative Diagnostics |
200 µg |
EUR 987 |
|
Description: Rabbit |
Surfactant protein D (SFTPD) (Conformational epitope) mouse monoclonal antibody, clone IIE11 (SPDE), Purified |
BM4083 |
Origene Technologies GmbH |
250 µg |
Ask for price |
AccuRuller 1Kb DNA Ladders |
02003-500 |
MaestroGen |
50μg |
Ask for price |
AccuRuller 100bp DNA Ladders |
02001-500 |
MaestroGen |
50μg |
EUR 25 |
AccuRuller 1Kb plus DNA Ladders |
02004-500 |
MaestroGen |
50μg |
EUR 25 |
AccuRuller 100bp Plus DNA Ladders |
02002-500 |
MaestroGen |
50μg |
EUR 25 |
AccuRuller RGB Prestained Protein Ladders |
02101-250 |
MaestroGen |
each |
EUR 35 |
Description: 250μl (100 loadings) |
AccuRuller RGB PLUS Prestained Protein Ladders |
02102-250 |
MaestroGen |
each |
EUR 40 |
Description: 250μl (100 loadings) |
HPV |
MBS370080-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
HPV-16 E6 + HPV-18 E6 Antibody |
V8334-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximately 90% of cervical cancers contain HPV DNA of the high risk types. Mutational analysis has shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro. |
HPV-16 E6 + HPV-18 E6 Antibody |
V8334-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximately 90% of cervical cancers contain HPV DNA of the high risk types. Mutational analysis has shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro. |
HPV-16 E6 + HPV-18 E6 Antibody |
V8334SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximately 90% of cervical cancers contain HPV DNA of the high risk types. Mutational analysis has shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro. |
HPV-16 E6 Monoclonal antibody [Clone: HPV-13E2] |
HPV-13E2-100ug |
Biologicals |
100 ug |
EUR 141.79 |
|
Description: Identification of HPV-16 E6. |
HPV-16 E6 Monoclonal antibody [Clone: HPV-13E2] |
HPV-13E2-1mg |
Biologicals |
1 mg |
EUR 897.6 |
|
Description: Identification of HPV-16 E6. |
HPV-16 E6 Monoclonal antibody [Clone: HPV-13E2] |
HPV-13E2-500ug |
Biologicals |
500 ug |
EUR 479.6 |
|
Description: Identification of HPV-16 E6. |
HPV-18 E6 Monoclonal antibody [Clone: HPV-4G3] |
HPV-4G3-100ug |
Biologicals |
100 ug |
EUR 141.79 |
|
Description: Identification of HPV-18 E6. |